Ionis Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of…

Biotechnology
US, Carlsbad [HQ]

Balance Sheet

15 Sheets · Starting from 2009
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
657.00 550.00 484.00 545.00 847.00 955.00 956.00 912.00 1,322.00 2,667.00 3,233.00 2,390.00 2,612.00 2,534.00 2,990.00
Current
596.00 483.00 360.00 423.00 735.00 836.00 837.00 797.00 1,167.00 2,207.00 2,721.00 2,130.00 2,345.00 2,203.00 2,641.00
Non Current
61.00 67.00 124.00 122.00 111.00 119.00 119.00 114.00 154.00 459.00 512.00 260.00 267.00 331.00 348.00
Liabilities
355.00 305.00 313.00 362.00 468.00 698.00 755.00 812.00 903.00 1,480.00 1,548.00 1,547.00 1,840.00 1,961.00 2,603.00
Current
111.00 105.00 76.00 74.00 97.00 115.00 148.00 133.00 224.00 280.00 273.00 290.00 241.00 312.00 448.00
Non Current
243.00 200.00 237.00 288.00 370.00 582.00 606.00 679.00 678.00 1,200.00 1,275.00 1,257.00 1,599.00 1,649.00 2,155.00
Equity
312.00 244.00 171.00 182.00 378.00 257.00 200.00 99.00 418.00 1,187.00 1,685.00 843.00 772.00 573.00 386.00
Stockholders' Equity
302.00 244.00 171.00 182.00 378.00 257.00 200.00 99.00 330.00 1,048.00 1,471.00 843.00 772.00 573.00 386.00
Retained Earnings
-696.00 -756.00 -841.00 -906.00 -967.00 -1,006.00 -1,094.00 -1,181.00 -1,187.00 -967.00 -707.00 -1,249.00 -1,159.00 -1,429.00 -1,795.00
Common Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Preferred Stock
10.00 - - - - - - - - - - - - - - - - - - - - - - - - - - 32.00
Profit
155.00 -61.00 -84.00 -65.00 -60.00 -38.00 -88.00 -86.00 -5.00 273.00 294.00 -487.00 -29.00 -270.00 -366.00
Dividends
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Minority Interest
10.00 - - - - - - - - - - - - - - 87.00 139.00 214.00 - - - - - - - -
Other Stockholders' Equity
985.00 1,000.00 1,013.00 1,077.00 1,324.00 1,224.00 1,309.00 1,311.00 1,549.00 2,047.00 2,203.00 2,113.00 1,964.00 2,059.00 2,182.00
Loss Other Compr. Income
2.00 - - - - 12.00 21.00 39.00 -13.00 -30.00 -31.00 -32.00 -25.00 -21.00 -32.00 -57.00 -32.00
End of IONS's Analysis
CIK: 874015 CUSIP: 462222100 ISIN: US4622221004 LEI: - UEI: -
Secondary Listings
IONS has no secondary listings inside our databases.